Literature DB >> 1560191

Remission of Raynaud's phenomenon after L-thyroxine therapy in a patient with hypothyroidism.

A M Lateiwish1, J Fehér, K Baraczka, K Rácz, R Kiss, E Gláz.   

Abstract

A 50-year-old man is described who had a 15-year history of Raynaud's phenomenon with severe and frequent vasospastic attacks in his fingers and toes during the past years. Exacerbation of his digital symptoms, which started about 4 years ago, was accompanied by signs of thyroid deficiency, such as tiredness, memory impairment, decreased libido, constipation, dryness of skin and bradycardia. Hormonal evaluation revealed primary hypothyroidism and the patient began substitution therapy with L-thyroxine. After 2 months of treatment not only did he become euthyroid but the digital symptoms also disappeared. The patient may thus represent one of the very few cases whose thyroid replacement therapy proved to be highly effective in treating both hypothyroidism and Raynaud's phenomenon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560191     DOI: 10.1007/BF03348657

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Occlusive arterial disease in the hand due to occupational trauma.

Authors:  I J SCHATZ
Journal:  N Engl J Med       Date:  1963-02-07       Impact factor: 91.245

2.  Treatment of Raynaud's phenomenon with large doses of triiodothyronine: a pilot study.

Authors:  P H Dessein; R F Gledhill
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

3.  Raynaud's phenomenon in a female population: prevalence and association with other conditions.

Authors:  J Leppert; H Aberg; I Ringqvist; S Sörensson
Journal:  Angiology       Date:  1987-12       Impact factor: 3.619

4.  How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases.

Authors:  P Priollet; M Vayssairat; E Housset
Journal:  Am J Med       Date:  1987-09       Impact factor: 4.965

5.  Tri-iodothyronine in Raynaud's phenomenon: further objective evidence of its beneficial effect.

Authors:  P H Dessein; R F Gledhill
Journal:  Br J Rheumatol       Date:  1988-06

6.  Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

Authors:  N J Christensen
Journal:  Clin Sci Mol Med       Date:  1973-08

Review 7.  Hand-arm vibration syndrome: a new clinical classification and an updated British standard guide for hand transmitted vibration.

Authors:  W Taylor
Journal:  Br J Ind Med       Date:  1988-05

Review 8.  The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness.

Authors:  J P Bilezikian; J N Loeb
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

9.  Raynaud's phenomenon and thyroid deficiency.

Authors:  B P Shagan; S A Friedman
Journal:  Arch Intern Med       Date:  1980-06

10.  Raynaud's phenomenon in hypothyroidism.

Authors:  B P Shagan; S A Friedman
Journal:  Angiology       Date:  1976-01       Impact factor: 3.619

View more
  2 in total

1.  The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients.

Authors:  Yathao Paolee; Chingching Foocharoen; Suranut Charoensri; Mayfong Mayxay; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

2.  The effect of vitamin D3 and thyroid hormones on the capillaroscopy-confirmed microangiopathy in pediatric patients with a suspicion of systemic connective tissue disease-a single-center experience with Raynaud phenomenon.

Authors:  Katarzyna Kapten; Krzysztof Orczyk; Elzbieta Smolewska
Journal:  Rheumatol Int       Date:  2021-06-16       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.